课题基金 / 基金详情

INFECTION AND REPLICATION OF NATURALLY OCCURRING HEPATITIS C VIRUS

INFECTION AND REPLICATION OF NATURALLY OCCURRING HEPATITIS C VIRUS
天然丙型肝炎病毒的感染和复制
批准号:
7722452
负责人:
MARTINA BUCK
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2009-04-30

项目摘要

项目成果

MARTINA BUCK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hepatitis C virus (HCV) infection afflicts about 170 million individuals worldwide. However, the HCV life cycle is partially understood because it has not been possible to infect human hepatocytes in culture. The current Huh-7 systems use cloned, synthetic HCV RNA expressed in hepatocellular carcinoma cells to produce pseudo particles, but these cells cannot be infected with naturally occurring HCV obtained from infected patients. Here, we describe a human hepatocyte culture permissible to the infection with naturally occurring HCV genotypes 1, 2, 3 and 4 in the blood of HCV-infected patients. The culture system mimics the biology and kinetics of HCV infection in humans, and produces infectious virions that can infect na¿ve human hepatocytes. This culture system should complement the existing systems, and may facilitate the understanding of the HCV life cycle, it effects in the natural host cell, the hepatocyte, as well as the development of novel therapeutics and vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY
  • 批准号:
    10095347
  • 项目类别:
  • 资助金额:
    $113.61万
  • 财政年份:
    2019
  • 负责人:
    MARTINA BUCK
  • 依托单位:
TREATMENT OF LUNG FIBROSIS : IND PHARMACOLOGY AND TOXICOLOGY
  • 批准号:
    10026462
  • 项目类别:
  • 资助金额:
    $132.7万
  • 财政年份:
    2019
  • 负责人:
    MARTINA BUCK
  • 依托单位:
Targeting C/EBP-beta Phosphorylation for the Treatment of Lung Fibrosis
  • 批准号:
    8904981
  • 项目类别:
  • 资助金额:
    $31.61万
  • 财政年份:
    2015
  • 负责人:
    MARTINA BUCK
  • 依托单位:
C/EBP-beta PEPTIDES FOR THE TREATMENT OF LUNG INJURY AND FIBROSIS
  • 批准号:
    8779048
  • 项目类别:
  • 资助金额:
    $31.18万
  • 财政年份:
    2014
  • 负责人:
    MARTINA BUCK
  • 依托单位:
海外基金